Aristotle University Of Thessaloniki (AUTH)
Η επίδραση του levosimendan στη μυοκαρδιακή λειτουργία σε επεμβάσεις αορτοστεφανιαίας παράκαμψης
Abstract
dc:descriptionAfter separation from cardiopulmonary bypass and at least 15 min after protamine administration, fifty patients who met the hemodynamic entry criteria (CI < 2L/min/m², PCWP >18 mm Hg, mBP > 70 mm Hg, SVR > 1500 dyn/sec/cm⁵, HR < 90/min, preoperative LVEF <40%) divided to 2 groups equal in number and randomly assigned to receive Levosimendan or Dobutamine. Levosimendan was administrated as a loading dose of 12γ/kg during 10 min followed of 10γ/kg/min. Dobutamine was started as a continuous infusion of 10γ/kg/min. After 10 min interval, an upward adjustment to 20 γ/kg/min could be made if clinically indicated. Our results not only confirm the findings of previous studies but extend them in patients with myocardial dysfunction after CPB and low preoperative LVEF, and indicate that loading dose followed by continuous infusion of Levosimendan produce immediate and sustained (because of the existance of active metabolites) increase in CO and reduction in SVR and PCWP in patients undergoing CABG. All hemodynamic parameters in Levosimendan group exhibited statistically significant improvement in relation to the Dobutamine group. The increase in CO resulted from the increased SV. The increased SV probably resulted from the combined actions of reduced LV afterload and increased inotropism. Notably the hemodynamic benefits of Levosimendan were not attenuated by β-blockers. The statistically significant decrease of PCWP values in Levosimendan group was associated with morphological changes in PCWP-waveform, indicative of reversal of ischemia. The results of the present study indicate that Levosimendan can be effectively used early management of low cardiac output syndrome after CABG and is not a drug of last resort.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsotsolis, Nikolaos
- Τσοτσόλης, Νικόλαος
Subjects
dc:subject × 16- Ευαισθητοποιητής ασβεστίου
- Λεβοσιμεντάνη
- Ντομπιουταμίνη
- Β - αποκλειστής
- Μυοκαρδιακή ισχαιμία
- Μυοκάρδιο, Απόπληκτο
- Calcium sensitizer
- Dobutamine
- B - blockers
- Myocardial ischemia
- Myocardial dysfunction following cardiopulmonary bypass
- Stunning
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19559